Sektor Monte Rosa Therapeutics, Inc.

Aktien

A3CS44

US61225M1027

GLUE

Biotechnologie

Markt geschlossen - Nasdaq 22:00:00 22.06.2026 % 5 Tage Veränd. 1. Jan.
18.67 USD +1.97% Intraday Chart für Monte Rosa Therapeutics, Inc. +3.04% +19.07%
Hauptkonkurrenten
% % 5 Tage Veränd. 1 Monat Veränd. 3 Monate % 1. Jan. % 1 Jahr Veränd. 3 Jahre Veränd. 5 Jahre Veränd. 10 Jahre Kap.($)
+1.97%+3.04%-0.74%+19.45%+19.07%+303.24%+173.75% - - 1.58 Mrd.
+2.66%+3.96%+4.58%+9.97%-4.43%-8.38%-2.98%-20.43%+217.87% 43.24 Mrd.
+1.73%+3.59%+9.40%+73.12%+108.17%+318.08%+564.04%+403.52% - 35.25 Mrd.
+0.61%+1.34%-12.39%-1.26%-10.54%+10.00%+46.20%-18.26%+749.91% 30.22 Mrd.
+0.02%-5.93%-0.05%+1.05%-25.55%+8.45%-21.44%-31.22%+162.53% 28.01 Mrd.
-1.06%-3.71%-10.96%-12.41%-2.25%+9.08%+19.56%-25.20%+149.52% 24.08 Mrd.
-1.23%+2.11%-7.71% - - - - - - 14.16 Mrd.
-0.99%-2.53%+5.28%+0.70%-18.87%+47.29%+102.88%+149.25% - 13.01 Mrd.
+2.14%+3.38%+2.53%+6.71%+3.91%+8.94%+14.60%-30.98%+90.15% 12.7 Mrd.
+2.39%+2.61%+0.44%+6.90%-4.07%+102.86%+84.20%+101.35%+235.95% 12.54 Mrd.
-3.61%-4.73%+20.51%+41.15%-22.77%-3.93%-38.09%-33.72%+110.45% 10.78 Mrd.
-5.88%-8.54%+3.62%+1.90%-18.97%-29.95% - - - 8.59 Mrd.
-4.02%-1.00%+15.35%+8.02%-5.44%+11.47%-27.32%-49.66%+100.05% 8.71 Mrd.
-1.86%-3.67%+13.26%+18.20%-8.98%+23.13%-11.07%-50.12%+117.91% 8.75 Mrd.
+7.47%+14.69%-11.69%+1.70%+2.93%+616.56%+1’658.78%+3.04% - 8.46 Mrd.
+3.61%+6.40%-22.76%-12.15%-26.16%+1’616.22%+454.24%+191.00%+1’493.19% 7.83 Mrd.
-1.81%-1.97%+3.16%-9.14%-23.36%-26.29%-28.44%-31.50%+43.91% 7.5 Mrd.
+2.29%+3.74%+25.05%+63.48%+64.47%+58.20%+36.84%+89.85%+6.92% 7.67 Mrd.
+9.97%+16.19%+26.06%+27.65%+27.81%+116.81%+324.46%+123.53% - 8.18 Mrd.
+1.92%+2.29%+15.97%+16.34%+31.70%+115.65%+317.68%+165.05% - 7.4 Mrd.
Durchschnitt +0.70%+0.78%+3.94%+13.76%+4.56%+173.55%+203.77%+55.03%+289.86% 14.93 Mrd.
Gewichteter Durchschnitt nach Marktkapitalisierung +0.61%+0.23%+2.20%+15.07%+8.38%+119.62%+165.97%+62.33%+294.53%
Biotechnologie und medizinische Forschung - Andere
  1. Börse
  2. Aktien
  3. A3CS44 Aktie
  4. Sektor Monte Rosa Therapeutics, Inc.
-40 %: Exklusive Verlängerung
T
:
:
PROFITIEREN SIE JETZT